| Dr Richard Nicholas Hubbell, MD | |
|
111 Colchester Ave, West Pavilioin-level 4, Burlington, VT 05401-1473 | |
| (802) 847-8475 | |
| (802) 847-8198 |
| Full Name | Dr Richard Nicholas Hubbell |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 44 Years |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790716637 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YP0228X | Otolaryngology - Pediatric Otolaryngology | 042-0006702 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
Alpha II, a leader in healthcare coding, compliance and reimbursement, announced today a new integration contract with Allscripts, the leading provider of clinical software, information and connectivity solutions for physicians. Alpha II's ClaimStaker software will soon be offered as an integrated solution to the Allscripts client base currently using MyWay, Tiger PM and Vision PM. Alpha II's CodeWizard will also be integrated into the Allscripts MyWay application. Estimated date of completion for the integrations is Q1 2011 for MyWay and Tiger, and Q2 2011 for integration into Vision.
The benefit of lowering low-density lipoprotein (LDL) cholesterol depends on how it is lowered, according to late-breaking results from a naturally randomised genetic trial presented today in a Hot Line - LBCT Session at ESC Congress1 and published in JAMA.
Older adults who go to the emergency department (ED) for an illness or injury are at increased risk for disability and decline in physical abilities up to six months later, according to a study by Yale researchers.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets 100 mg/12.5 mg, the generic version of Merck and Co., Inc.'s antihypertensive Hyzaar®.
The federal government has committed $11 billion to expand the operating capacity of Federally Qualified Health Centers (FQHC), which receive federal funding and enhanced Medicaid and Medicare reimbursement, and "look-alike" clinics that receive enhanced reimbursement but no federal grants.
› Verified 6 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Alpha II, a leader in healthcare coding, compliance and reimbursement, announced today a new integration contract with Allscripts, the leading provider of clinical software, information and connectivity solutions for physicians. Alpha II's ClaimStaker software will soon be offered as an integrated solution to the Allscripts client base currently using MyWay, Tiger PM and Vision PM. Alpha II's CodeWizard will also be integrated into the Allscripts MyWay application. Estimated date of completion for the integrations is Q1 2011 for MyWay and Tiger, and Q2 2011 for integration into Vision.
The benefit of lowering low-density lipoprotein (LDL) cholesterol depends on how it is lowered, according to late-breaking results from a naturally randomised genetic trial presented today in a Hot Line - LBCT Session at ESC Congress1 and published in JAMA.
Older adults who go to the emergency department (ED) for an illness or injury are at increased risk for disability and decline in physical abilities up to six months later, according to a study by Yale researchers.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets 100 mg/12.5 mg, the generic version of Merck and Co., Inc.'s antihypertensive Hyzaar®.
The federal government has committed $11 billion to expand the operating capacity of Federally Qualified Health Centers (FQHC), which receive federal funding and enhanced Medicaid and Medicare reimbursement, and "look-alike" clinics that receive enhanced reimbursement but no federal grants.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Nicholas Hubbell, MD 80 Summit St, Burlington, VT 05401-3928 Ph: (802) 847-8475 | Dr Richard Nicholas Hubbell, MD 111 Colchester Ave, West Pavilioin-level 4, Burlington, VT 05401-1473 Ph: (802) 847-8475 |
News Archive
Alpha II, a leader in healthcare coding, compliance and reimbursement, announced today a new integration contract with Allscripts, the leading provider of clinical software, information and connectivity solutions for physicians. Alpha II's ClaimStaker software will soon be offered as an integrated solution to the Allscripts client base currently using MyWay, Tiger PM and Vision PM. Alpha II's CodeWizard will also be integrated into the Allscripts MyWay application. Estimated date of completion for the integrations is Q1 2011 for MyWay and Tiger, and Q2 2011 for integration into Vision.
The benefit of lowering low-density lipoprotein (LDL) cholesterol depends on how it is lowered, according to late-breaking results from a naturally randomised genetic trial presented today in a Hot Line - LBCT Session at ESC Congress1 and published in JAMA.
Older adults who go to the emergency department (ED) for an illness or injury are at increased risk for disability and decline in physical abilities up to six months later, according to a study by Yale researchers.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets 100 mg/12.5 mg, the generic version of Merck and Co., Inc.'s antihypertensive Hyzaar®.
The federal government has committed $11 billion to expand the operating capacity of Federally Qualified Health Centers (FQHC), which receive federal funding and enhanced Medicaid and Medicare reimbursement, and "look-alike" clinics that receive enhanced reimbursement but no federal grants.
› Verified 6 days ago
Tamara Rimash, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Dr. George Kurien, MD FRCSC Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-4537 Fax: 802-847-8198 | |
Erin Tracy Ostby, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave Fl 4, Burlington, VT 05401 Phone: 802-847-4535 Fax: 802-847-8198 | |
Dr. William John Brundage, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, West Pavilion-level 4, Burlington, VT 05401 Phone: 802-847-4535 Fax: 802-847-8198 | |
Dr. Donna Jean Millay, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, West Pavilion-level 4 Otolaryngology, Burlington, VT 05401 Phone: 802-847-4537 Fax: 802-847-8198 | |
Dr. Gary Patrick Landrigan, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, West Pavilion-level 4, Burlington, VT 05401 Phone: 802-847-9393 Fax: 802-847-8198 | |
Heather Chambless Herrington, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2700 |